Side-by-side comparison of AI visibility scores, market position, and capabilities
Connected fitness company with $3B revenue and 3M subscribers; premium bikes with live classes from celebrity instructors executing turnaround through cost cuts and hotel/commercial partnerships.
Peloton is a connected fitness company known for its premium exercise bikes and treadmills with built-in touchscreens and subscription-based on-demand and live streaming fitness classes — creating an immersive home workout experience led by celebrity instructors that became a cultural phenomenon during COVID-19. Listed on NASDAQ (NASDAQ: PTON) and headquartered in New York City, Peloton generates approximately $3 billion in annual revenue and has approximately 3 million connected fitness subscribers, though the company has been navigating significant financial challenges following the post-pandemic demand normalization.\n\nPeloton's platform combines hardware (Bike, Bike+, Tread, Tread+, Row, and Guide strength tracking camera) with Peloton Membership ($44/month per household for unlimited classes) that provides access to thousands of live and on-demand classes across cycling, running, strength, yoga, meditation, and stretching. The instructor-celebrity model — trainers like Robin Arzón, Cody Rigsby, and Alex Toussaint with millions of Instagram followers — creates strong community and loyalty that pure fitness equipment lacks.\n\nIn 2025, Peloton is executing a turnaround strategy under CEO Barry McCarthy (who replaced founder John Foley in 2022) focused on reducing costs, growing the app business, and expanding hardware availability through partnerships (Peloton bikes available for rental at hotel gyms, in-room Peloton bikes at Westin and Marriott hotels). The company has reduced headcount significantly and outsourced manufacturing. Peloton competes with NordicTrack/iFIT (IFIT Health & Fitness) for premium home fitness equipment and with Apple Fitness+ for connected workout content. The 2025 strategy focuses on improving unit economics, growing Peloton App subscriptions (app-only, without hardware), and expanding commercial market placement.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.